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Summary
Objectives: To evaluate the prevalence and associated presentations of hypoglycemia in bac-
teremic pneumococcal infections, and serotypes of the isolates.
Methods: This was a retrospective study of 70 episodes of pneumococcal bacteremia that
occurred in 2004 and 2005.
Results: We found hypoglycemia (plasma glucose <3.05 mmol/l)) in six (8.6%) episodes. The
patients were three children (mean age 3 years 1month; range 1 year 5months—4 years 5months)
and three adults (mean age 73.3 years; range 63—84 years). One child with asplenia and cyanotic
heart disease had primary pneumococcal bacteremia. Of the other two children, one had
meningitis and the other pneumonia. All the adults had cancer with previous chemotherapy
and multilobar pneumonia, which progressed rapidly to respiratory failure. All patients devel-
oped their first hypoglycemic episode within two hours after presentation. The average plasma
glucose during hypoglycemia was 1.78  0.78 mmol/l (range 0.33—2.94 mmol/l). One child and
all of the adults died. Serotypes of isolates were those usually associated with severe pneumo-
coccal infection: 6B and 19F in the children; 3, 14, and 23F in the adults. Only the asplenic child
had received pneumococcal vaccine.
Conclusions: Hypoglycemia occurred in 8.6% of bacteremic pneumococcal infections and was
associated with high mortality and serotypes that cause severe invasive disease. All patients
suspected of having septicemia should have their glucose checked to avoid missing hypoglycemia
leading to a worsening of their already poor condition.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +886 2 23123456x5359;
fax: +886 2 23224263.
E-mail address: linalee@ntu.edu.tw (L.-N. Lee).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.08.026Introduction
Hypoglycemia has rarely been associated with severe infec-
tion,1 except in cases ofmalaria2—4 and shigellosis.5,6 In 1934,Published by Elsevier Ltd. All rights reserved.
Hypoglycemia in pneumococcal bacteremia 571Magnusson7 reported the first three cases of bacteremia-
associated hypoglycemia in children with fulminant menin-
gococcemia and adrenal hemorrhage. In a few subsequent
case reports, hypoglycemia was found to occur in severe
sepsis caused by the encapsulated bacteria Streptococcus
pneumoniae, Haemophilus influenzae, and Neisseria menin-
gitidis,1,8—11 and to be an index of grave outcome. The
reported cases were young children,1,7 or adults who were
splenectomized,1,8,9,11 alcoholic,1 or on chronic dialysis.1,9,11
The prevalence of hypoglycemia in pneumococcal septice-
mia, however, has never been studied. We conducted a
retrospective study to evaluate the prevalence of hypogly-
cemia in patients with bacteremic pneumococcal infections,
and to present the clinical course of the disease and ser-
otypes of the pneumococcal isolates.
Materials and methods
Patients
This study was conducted at a 2000-bed university hospital in
northern Taiwan. We retrospectively searched the computer
database of our microbiology laboratory and retrieved all
patients with at least one blood culture positive for S.
pneumoniae from January 2004 through December 2005.
We then reviewed their charts and identified all patients
with hypoglycemia (plasma glucose level of<3.05 mmol/l).12
For the purposes of comparison, we also obtained a list of
patients with bacteremia due to Staphylococcus aureus and
due to Escherichia coli for the year 2004, and studied the
prevalence of hypoglycemia in these two groups.
The infection that led to pneumococcal bacteremia was
determined to be: (1) pneumonia, if there were clinical pre-
sentationsofpneumonia and lobarpneumonic infiltrates at the
initial chest radiograph, with or without concomitant isolation
of S. pneumoniae from blood and sputum; (2) meningitis, if
there were clinical manifestations of meningitis and isolation
of S. pneumoniae from the cerebrospinal fluid; (3) sponta-
neous peritonitis, if there were clinical presentations of peri-
tonitis, isolation of S. pneumoniae from ascites, and no
evidenceof rupturedhollowviscus. Pneumococcal bacteremia
was definedasprimary, if therewerenoclinicalmanifestations
of local pneumococcal infection and S. pneumoniae was not
isolated from sites other than blood. Septic shock was defined
as previously stated.13 Acute respiratory distress syndrome
(ARDS) was defined by bilateral pulmonary infiltrates on chestTable 1 Pneumococcal infections causing bacteremia 2004—200
Pneumococcal infection
causing bacteremia
Number of episodes
Adults
Community-acquired
Pneumonia 31
Primary bacteremia 10
Meningitis 4
Spontaneous bacterial peritonitis 1
Total 46
a All were community-acquired.radiograph, a ratio of arterial oxygen tension (PaO2) to the
fraction of inspired oxygen (FiO2) of 200 or less, and the
absence of evidence of left atrial hypertension.14
Drug susceptibility
All S. pneumoniae isolates were tested for drug susceptibility
by the standardized disk diffusion methods.15 Minimum inhi-
bitory concentration (MIC) tests were performed by the
microdilution method for the isolates from patients with
hypoglycemia.15
Antibiotic treatment was considered concordant if at least
one of the antibiotics administered during the first 24 hours
showed full in vitro sensitivity against the isolated strain.
Therapies without this criterion were defined as discordant.
Serotyping and serogrouping of isolates
Serotyping was performed by slide agglutination with cap-
sular typing sera and factor sera (Statens Serum Institut,
Copenhagen, Denmark).
Data analysis
The Student’s t-test was used to analyze inter-group differ-
ences for the age between patients with and those without
hypoglycemia. The Chi-square test was used to compare
differences in the seasonal occurrence and mortality
between patients with and those without hypoglycemia.
Results
Case identification
During the years 2004 and 2005, there were 70 episodes (69
patients) of bacteremia due to S. pneumoniae (Table 1). Fifty
episodes (71%) occurred in 49 adults (38 male, 78%), their
average age being 59.8  20.0 years (range18—92 years). Four
were nosocomial. Twenty episodes occurred in children (14
male, 70%), with a mean age of 3 years 10 months (range 3
months—14 years; 70% <4 years). Pneumonia was the most
common disease leading to bacteremia: 31/50 adults (62%)
and 12/20 children (60%). Half of the children, and all of the
adults except for one who was dead on arrival with unknown
previous health condition, had an underlying disease (Table 2).5.
Childrena Total
Nosocomial
0 12 43
3 4 17
1 4 9
0 0 1
4 20 70
Table 2 Major underlying diseases of patients with bactere-
mic pneumococcal infection.
No. (%) with
known underlying
disease
Underlying disease Number
(%)
Adults: 48 (98) Solid cancer 17 (34.7)
Leukemia and myeloma 4 (8.2)
Chronic obstructive
pulmonary disease
7 (14.3)
Diabetes mellitus 5 (10.2)
Alcoholic cirrhosis 4 (8.2)
Cirrhosis, other causes 2 (4.1)
Aortic aneurysm 3 (6.1)
HIV infection 2 (4.1)
Others 4 (8.2)
Children: 10 (50) Asthma 4 (20)
Asplenism + CHD,a VSD,b
bronchiectasis, biliary
atresia post-liver-transplant,
angiomatosis under cytoxan,
atopic dermatitis
Each 1 (5)
a Congenital heart disease (right atrial isomerism, total anom-
alous pulmonary return, endocardial cushion defect, and double
outlet right ventricle).
b Ventricular septal defect.
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572 I.-S. Jan et al.Prevalence and seasonality
Plasma glucose was analyzed in 55 episodes. For the rest, the
patients showed no signs of hypoglycemia. Hypoglycemia was
documented in six episodes (8.6%) (Table 3). The patients
were three children (one male; mean age 3 years 1 month)
and three adults (all male; mean age 73.3 years). None had
diabetes, alcoholism, chronic renal failure, or history of
insulinoma, hypothyroidism, or hypoadrenalism. Two chil-
dren were previously healthy, while all three adults had
underlying cancer. The previous plasma glucose levels of
all three adults were normal. All six episodes of pneumococ-
cal bacteremia with hypoglycemia occurred in the cooler
part of the year (October through March), while in adults
without hypoglycemia, 24 episodes (51%, p = 0.292), and in
children without hypoglycemia, 10 episodes (59%, p = 0.455),
occurred during cooler seasons.
For the comparison with patients with bacteremia due to
otherpathogens,wefoundthat in theyear2004therewere601
episodes of bacteremia due to S. aureus and 689 episodes of
bacteremia due to E. coli. In 227 (38%) of the 601 and 242 (35%)
of the 689 episodes, plasma glucose levelswere checked.After
excluding those hypoglycemic episodes that were related to
insulin administration or liver cirrhosis, we found sepsis-asso-
ciated hypoglycemia in three episodes (0.5%) of bacteremia
due to S. aureus and two episodes (0.3%) of bacteremia due to
E. coli. These five hypoglycemic episodes occurred in January,
March, April, July, and October (one in each).
Clinical presentation
Clinical presentation differed between adults and children
(Table 2). All three children had high fever at presentation
(average 39.4 8C). The two previously healthy children did
Figure 1 Chest radiograph of patient 6 at presentation (A),
showing lobar consolidation of right lower, right middle, and part
of the left lower lobe, and 24 hours later (B), showing rapid
progression of the pneumonic process.
Hypoglycemia in pneumococcal bacteremia 573not have shock or respiratory failure, despite one experien-
cing a severe meningoencephalitis and the other a pneumo-
nia complicated with multiple lung abscesses. The only child
who died was congenitally asplenic. On arrival at the emer-
gency room, she had shock, generalized petechiae, and
severe hypoxemia (oxygen saturation 37%, her usual satura-
tion being 80% due to congenital heart disease with an
intracardiac shunt). Among the six hypoglycemic patients
she was the only one who had received a 23-valent pneumo-
coccal vaccine (the conjugate vaccine was not available
locally).
All three adults had pneumococcal pneumonia. On arriv-
ing at the emergency service, none was febrile or hypother-
mic, but all were in hypoxemia and impending respiratory
failure (oxygen saturation 80%, 82%, and 74%, for cases 4, 5,
and 6, respectively; Table 3). One was in shock. Two had lived
in a nursing home, but all three had been ambulatory. Cases
4, 5, and 6 were receiving anti-cancer chemotherapy 8, 16,
and 8 days, respectively, before the onset of pneumonia. The
intermittently scheduled chemotherapy had been started 18,
7, and 3 months, respectively, before bacteremia developed.
The first chest radiograph of all three adult patients showed
multilobar pneumonia, which progressed rapidly to nearly
complete bilateral opacification (Figure 1).
Hypoglycemia
Table 3 shows plasma glucose levels of the six patients during
the initial 24 hours. In this period each patient had two to six
measurements of plasma glucose taken, and one to three
documented episodes of hypoglycemia. A total of 10 hypo-
glycemic episodes were documented in the six patients; none
presented with cold clammy skin or sweating. The boy with
meningoencephalitis and the girl with asplenism were coma-
tose at presentation. After glucose and antimicrobial ther-
apy, the mentality of the boy improved slowly over several
days; the girl never woke up. All three adults hadmild mental
drowsiness at presentation that became clearer after glucose
infusion. The average glucose level during hypoglycemia was
1.78  0.78 mmol/l (range 0.33—2.94 mmol/l). All six
patients documented their first hypoglycemic episode within
two hours after arrival. For patients 1—5, hypoglycemia was
detected only in the first four hours after arrival. Patient 6,
however, had recurrent, severe hypoglycemia, despite con-
stantly being treated with intravenous glucose. The last
hypoglycemic episode (0.33 mmol/l, or 6 mg/dl) was docu-
mented 18 hours after arrival, 17 hours after antimicrobials
and glucose infusion were started. The two patients who had
glucose <1.67 mmol/l, or 30 mg/dl (patients 3 and 6) died
rapidly.
Other laboratory data
S. pneumoniae was isolated from sputum samples of two
adult patients (patients 5 and 6, Table 3). Both had a fulmi-
nant course. White blood cell count ranged from 3.55 to
26.3  109/l. Tests for disseminated intravascular coagula-
tion (DIC) were performed in four, and all were positive. The
initial level of C-reactive protein (CRP) was markedly ele-
vated (173 to 322 mg/l) except in the child with cyanotic
congenital heart disease (39 mg/l). All three adults were
hypoalbuminemic.
Table 4 Serotype, serogroup, drug susceptibility, and minimal inhibitory concentration of pneumococcal isolates.
Case No. Age Serogroup/
serotype
Drug susceptibility by disk diffusion method MIC (mg/ml) Initial antibiotics
Pc Ery Clin Tet Cm Van Levo Pca Cro Van
1 1y5m 6B R R S R S S S 5 (R/R) 0.25 0.12 Van + cefotaxime
2 3y6m 6B R R S R S S S 2 (R/S) 1 0.25 Cro
3 4y5m 19F R R R R S S S 2 (R/S) 0.5 0.12 Van + ceftazidime
4 84y 3 S R R R R S S 0.03 (S/S) 0.03 0.12 Flomoxefb
5 74y 14 R R R S S S S 0.25 (I/S) 0.06 0.25 Amoxicillin—
clavulanate
6 63y 23F R R R R S S S 4 (R/R) 2 0.25 Cefepime
MIC, minimum inhibitory concentration; Pc, penicillin; Ery, erythromycin; Clin, clindamycin; Tet, tetracycline; Cm, chloramphenicol; Van,
vancomycin; Levo, levofloxacin; Cro, ceftriaxone; R, resistant; S, susceptible; I, intermediate; y, years; m, months.
a Based on the penicillin MIC interpretative criteria for Streptococcus pneumoniae (meningitis/non-meningitis) of the Clinical and
Laboratory Standards Institute (CLSI) 2008.15.
b A cephamycin with a difluoromethylthioacetamido group at position 7.
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Table 4 shows the serotypes, drug susceptibilities, and MICs of
the six pneumococcal isolates, and the initial antimicrobial
therapy the patients received. Although five of the six iso-
lates were resistant to penicillin by disk diffusion method,
MIC testing showed that only two isolates were resistant: one
from the boy with meningitis with a MIC of 5 mg/ml, the other
from a pneumonia patient with a MIC of 4 mg/ml.15 Only
patient 5 received a discordant initial antimicrobial. Others
were treated with concordant initial antimicrobials including
third- or fourth-generation cephalosporins, with or without
vancomycin.
Course and fatality
Among the three children, only the one with asplenia, con-
genital heart disease, and primary bacteremia died of ful-
minant septicemia (mortality 33.3%). The boy with
meningitis recovered but had sequela of mental retardation
and seizures. The mortality among 17 children with bactere-
mic pneumococcal infection but no hypoglycemia was 5.9%
(1/17, p = 0.677). All three adult patients progressed rapidly
to respiratory failure and required mechanical ventilation.
They all died of multilobar pneumonia with respiratory fail-
ure, with or without septic shock (Table 3). Compared with
adult patients who had pneumonia but no hypoglycemia
(n = 28), the average age was not different (73.7  10.5
vs. 60.1  20.7, p = 0.277), but the mortality was higher
(100% vs. 25%, p = 0.046).
Discussion
While hyperglycemia is often observed in the early phase of
sepsis,16 hypoglycemia due to sepsis has been described only
rarely. Sepsis has been reported to be the cause of hypogly-
cemia in 12% of hospitalized non-diabetic adults with hypo-
glycemia, other than chronic renal failure (25%), alcohol
intoxication (15%), and hepatic failure (12%).17 In rat and
dog sepsis, hypoglycemia is caused by an increased glucose
utilization by macrophage-rich tissues (liver, spleen, lung,ileum, skin),18,19 and decreased hepatic glucose produc-
tion.19,20 The incidence of hypoglycemia in septicemia, how-
ever, has never been reported. Our study shows that
hypoglycemia occurred in 8.6% of bacteremic pneumococcal
infections. This is probably an underestimate, as not all
patients had plasma glucose tested. Compared with bacter-
emia due to S. aureus or E. coli, the rate of hypoglycemia in
pneumococcal septicemia was higher, probably reflecting the
more invasive and fulminant nature of pneumococcal sepsis.
That all six episodes of hypoglycemia associated with pneu-
mococcal bacteremia occurred in the cooler part of the year
(October to March) probably reflects the fact that invasive
pneumococcal infections happen more often in cold
weather.21 The observation that hypoglycemic episodes
due to S. aureus or E. coli do not show such seasonal variation
probably supports this speculation.
Our patients with hypoglycemia were young or old. The
three hypoglycemic children had severe invasive disease,
resulting in one death and one mental retardation. Infec-
tion-associated hypoglycemia in children is well known in
malaria,2—4 and reported rarely in shigellosis,5,6 acute ful-
minant hepatitis,22 pancreatitis/gastroenteritis due to rota-
virus,23 and Reye’s syndrome.24 Septicemia-associated
hypoglycemia in children has been described in only four
cases,1,7 all due to Neisseria meningitidis. In our study it
occurred in three (15%) of the 20 pediatric patients, suggest-
ing it is probably not very rare. A routine measurement of
blood glucose for any pediatric patient suspected of having
sepsis may be needed, to avoidmissing its presence, resulting
in a worsening of an already severe disease.
The three adult hypoglycemic patients in our study all
died of pneumococcal pneumonia. In the few previous case
reports, hypoglycemia occurred in adult patients with septi-
cemia due to S. pneumoniae, H. influenzae, Streptococcus
pyogenes, S. aureus, Clostridium perfringens, and E. coli,
with a mortality of 67%.1,8,9,25—27 The reported patients were
mostly alcoholic,1 splenectomized,8,9,11 on chronic dialy-
sis,1,8,11 or cirrhotic.27 Our patients, on the other hand, were
receiving antineoplastic therapy for solid tumors before
acquiring pneumococcal pneumonia. Patients who are
receiving chemotherapy for cancer are immunosuppressed
and prone to develop severe infection, including pneumo-
coccal bacteremia.28 In cancer patients, pneumococcal
Hypoglycemia in pneumococcal bacteremia 575bacteremia is often accompanied by pneumonia, as in our
patients, but can be caused by infected catheters.28 The
latter could be the reason that in our study, as many as 13
(26%) of 50 adult episodes were primary bacteremia, for 43%
of our adult patients had cancer. Hypoglycemia has been
associated with non-islet cell tumors, especially mesothe-
lioma,29 and rarely pulmonary squamous cell carcinoma.30
Our patients had carcinoma of the colon, prostate, and lung,
but their tumors were not likely the cause of hypoglycemia,
for their previous blood glucose levels were all normal. None
of our patients had alcoholism, cirrhosis, or chronic renal
failure, which could cause hypoglycemia due to decreased
hepatic or renal gluconeogenesis.17 Thus in our patients,
bacteremic pneumococcal pneumonia was the most impor-
tant factor leading to hypoglycemia. We found that plasma
glucose could decline to as low as 0.33 mmol/l even after
17 hours of concordant antimicrobial and glucose therapy,
suggesting the necessity of monitoring blood glucose levels
even after its apparent normalization.
The isolates of our patients belong to those serotypes that
commonly cause invasive disease, and are covered in the 7-
or 23-valent vaccines.31 The hypoglycemia was not asso-
ciated with any specific serotype, but rather a manifestation
of severe pneumococcal infection. Previous studies have
shown that in invasive pneumococcal disease, serotype 3,
older age, leukopenia, hypothermia, nursing home resi-
dence, pre-existing lung disease, and need for mechanical
ventilation are predictors of mortality.32,33 Our study showed
that hypoglycemia was also a marker of poor prognosis; this
has often been missed, even in a large prospective study.33
Due to the severity of such infections, the presence of
hypoglycemia can be masked by the devastating condition.
Delay in its detection and treatment may worsen the already
poor prognosis. Other laboratory indices of poor prognosis
include DIC, a known marker of sepsis.34 Levels of CRP in our
patients were markedly high, except in the child with cya-
notic heart disease. Lower CRP levels have been reported in
children with right-to-left intracardiac shunt and chronic
hypoxemia than those with left-to-right shunt.35 The etiology
remains unknown.
Although five of the six patients received concordant
antimicrobials, the mortality remained very high. Thus pre-
vention of severe pneumococcal infection is more important
than choosing appropriate chemotherapy. The asplenic child
was the only one who had previously received pneumococcal
vaccine. The possible reason for vaccine failure may be that
the 23-valent vaccine she received could not elicit a suffi-
cient antibody response in asplenic patients.36 That all six
episodes occurred in October through March probably sug-
gests that high-risk populations should receive pneumococcal
vaccine no later than early September.
As for possible causes of hypoglycemia in this population,
we speculate that an overwhelming sepsis can cause hypo-
glycemia by: (1) increased glucose utilization by macro-
phage-rich tissues including liver, lung, spleen, ileum, and
skin,19 and (2) depressed hepatic gluconeogenesis that has
resulted from decreased sensitivity to stress hormones, and/
or adrenal failure.7,10,19
In summary, hypoglycemia developed in six (8.6%) of 70
episodes of bacteremic pneumococcal infection. The three
adult patients had received anti-cancer chemotherapy, and
all had multilobar pneumonia and hypoxemia at presenta-tion. One of the three children and all three adults died,
although five of them had received concordant antimicro-
bials. All patients suspected of having septicemia should have
blood glucose checked, to avoid missing hypoglycemia,
resulting in a worsening of an already poor condition. The
asplenic child who died was the only one who had received a
pneumococcal vaccine beforehand, although all the isolates
would have been covered by a 7- or 23-valent vaccine, and
the infection could have been prevented.
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